Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
Bergman M, Tundia N, Martin N, Suboticki JL, Patel J, Goldschmidt D, Song Y, Wright GC. Bergman M, et al. Among authors: wright gc. Arthritis Res Ther. 2022 Jun 24;24(1):155. doi: 10.1186/s13075-022-02813-x. Arthritis Res Ther. 2022. PMID: 35751108 Free PMC article. Clinical Trial.
Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al.
Curtis JR, Wright GC, Strand V, Davis CS, Hitraya E, Sasso EH. Curtis JR, et al. Among authors: wright gc. Arthritis Rheumatol. 2017 Apr;69(4):863-865. doi: 10.1002/art.39981. Epub 2017 Mar 3. Arthritis Rheumatol. 2017. PMID: 27813312 Free PMC article. No abstract available.
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.
Curtis JR, Weinblatt M, Saag K, Bykerk VP, Furst DE, Fiore S, St John G, Kimura T, Zheng S, Bingham CO 3rd, Wright G, Bergman M, Nola K, Charles-Schoeman C, Shadick N. Curtis JR, et al. Arthritis Care Res (Hoboken). 2021 Apr;73(4):471-480. doi: 10.1002/acr.24471. Epub 2021 Mar 13. Arthritis Care Res (Hoboken). 2021. PMID: 33002337 Free PMC article.
Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
Bergman M, Tundia N, Martin N, Suboticki JL, Patel J, Goldschmidt D, Song Y, Wright GC. Bergman M, et al. Among authors: wright gc. Arthritis Res Ther. 2022 Nov 3;24(1):248. doi: 10.1186/s13075-022-02940-5. Arthritis Res Ther. 2022. PMID: 36329507 Free PMC article. No abstract available.
Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States.
Dowell S, Yun H, Curtis JR, Chen L, Xie F, Pedra-Nobre M, Wollaston D, Najmey S, Elliott CL, Ford TL, North H, Dore R, Dolatabadi S, Ramanujam T, Kennedy S, Ott S, Jileaeva I, Richardson A, Kaine J, Wright G, Kerr GS. Dowell S, et al. ACR Open Rheumatol. 2023 Apr;5(4):181-189. doi: 10.1002/acr2.11532. Epub 2023 Feb 21. ACR Open Rheumatol. 2023. PMID: 36811270 Free PMC article.
64 results